top of page

The Cholangiocarcinoma Collaborative is pleased to invite you to the annual C3 meeting, MEET C3 2025, dedicated to advancing knowledge and collaboration within this challenging field.

Over three days, patients, physicians, clinicians, researchers, patient partners, and advocates will gather to discuss advancements in cholangiocarcinoma treatment, recent clinical research, and patient-centered care approaches. The conference will focus on the latest developments and treatment options specific to the Canadian context, providing valuable insights into the patient journey from both clinical and patient partner perspectives.

​

This event is a great opportunity to connect, learn, and share experiences with others dedicated to improving outcomes for those affected by cholangiocarcinoma.​

​​

​

Join us for this enriching event and be a part of the ongoing efforts to make a difference!

​Meet C3 2025
C3 bi-annual conference - Toronto April 4-6, 2025

Meet C3 Partners

639303bb2a61e512440672_edited.jpg
bc-cancer-mention_edited.jpg
CHCC logo.png
{BDEB9695-3F54-4829-AF55-8C8642D9C563}.png
{80B6895C-70CF-4DD9-B441-618FDB88BE3B}.png
{26DFD1C4-70B2-4407-8466-184D7D7BDC4B}.png
  • Instagram
  • Facebook
  • Youtube
  • Twitter
logoImage.png
leaf-cihr-colour-en_edited.png

Le Collectif Canadien pour le cholangiocarcinome (C3) est financé par une subvention d'équipe révolutionnaire de la Société Canadienne du cancer en partenariat avec les Instituts de recherche en santé du Canada. Les fonds de la subvention pour le C3 sont gérés par l'Institut de recherche de l'Hôpital d'Ottawa, qui sert d'institut principal pour toutes les opérations collaboratives.

© 2025 www.cholangio.ca. All rights reserved.

bottom of page